Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-08-16

Clinical Trial Update: Management of Pruritus With Xyzal in Atopic Dermatitis [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluated Xyzal (cetirizine) for managing pruritus in atopic dermatitis; results were completed and posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • XYZAL (LEVOCETIRIZINE DIHYDROCHLORIDE)

Snippet

Sponsor: Derm Research, PLLC | Conditions: Atopic Dermatitis, Pruritus | Phase 4 | Status: COMPLETED | Results posted: 2013-08-16